BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16543920)

  • 1. Immunosuppression promotes reovirus therapy of colorectal liver metastases.
    Smakman N; van der Bilt JD; van den Wollenberg DJ; Hoeben RC; Borel Rinkes IH; Kranenburg O
    Cancer Gene Ther; 2006 Aug; 13(8):815-8. PubMed ID: 16543920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 is a target of KRASD12, which facilitates the outgrowth of murine C26 colorectal liver metastases.
    Smakman N; Kranenburg O; Vogten JM; Bloemendaal AL; van Diest P; Borel Rinkes IH
    Clin Cancer Res; 2005 Jan; 11(1):41-8. PubMed ID: 15671526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient infection of freshly isolated human colorectal tumor cells by reovirus T3D intermediate subviral particles.
    van Houdt WJ; Smakman N; van den Wollenberg DJ; Emmink BL; Veenendaal LM; van Diest PJ; Hoeben RC; Borel Rinkes IH; Kranenburg O
    Cancer Gene Ther; 2008 May; 15(5):284-92. PubMed ID: 18259212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization to apoptosis underlies KrasD12-dependent oncolysis of murine C26 colorectal carcinoma cells by reovirus T3D.
    Smakman N; van den Wollenberg DJ; Borel Rinkes IH; Hoeben RC; Kranenburg O
    J Virol; 2005 Dec; 79(23):14981-5. PubMed ID: 16282499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic viral therapy for prostate cancer: efficacy of reovirus as a biological therapeutic.
    Thirukkumaran CM; Nodwell MJ; Hirasawa K; Shi ZQ; Diaz R; Luider J; Johnston RN; Forsyth PA; Magliocco AM; Lee P; Nishikawa S; Donnelly B; Coffey M; Trpkov K; Fonseca K; Spurrell J; Morris DG
    Cancer Res; 2010 Mar; 70(6):2435-44. PubMed ID: 20215509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of oncolytic reovirus against liver metastasis from pancreatic cancer in immunocompetent models.
    Himeno Y; Etoh T; Matsumoto T; Ohta M; Nishizono A; Kitano S
    Int J Oncol; 2005 Oct; 27(4):901-6. PubMed ID: 16142304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumoural immunity by virus-mediated immunogenic apoptosis inhibits metastatic growth of hepatocellular carcinoma.
    Boozari B; Mundt B; Woller N; Strüver N; Gürlevik E; Schache P; Kloos A; Knocke S; Manns MP; Wirth TC; Kubicka S; Kühnel F
    Gut; 2010 Oct; 59(10):1416-26. PubMed ID: 20675696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector.
    Kuroda T; Rabkin SD; Martuza RL
    Cancer Res; 2006 Oct; 66(20):10127-35. PubMed ID: 17047077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reovirus prolongs survival and reduces the frequency of spinal and leptomeningeal metastases from medulloblastoma.
    Yang WQ; Senger D; Muzik H; Shi ZQ; Johnson D; Brasher PM; Rewcastle NB; Hamilton M; Rutka J; Wolff J; Wetmore C; Curran T; Lee PW; Forsyth PA
    Cancer Res; 2003 Jun; 63(12):3162-72. PubMed ID: 12810644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine-secreting herpes viral mutants effectively treat tumor in a murine metastatic colorectal liver model by oncolytic and T-cell-dependent mechanisms.
    Derubertis BG; Stiles BM; Bhargava A; Gusani NJ; Hezel M; D'Angelica M; Fong Y
    Cancer Gene Ther; 2007 Jun; 14(6):590-7. PubMed ID: 17431402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KRAS(D13) Promotes apoptosis of human colorectal tumor cells by ReovirusT3D and oxaliplatin but not by tumor necrosis factor-related apoptosis-inducing ligand.
    Smakman N; van den Wollenberg DJ; Elias SG; Sasazuki T; Shirasawa S; Hoeben RC; Borel Rinkes IH; Kranenburg O
    Cancer Res; 2006 May; 66(10):5403-8. PubMed ID: 16707468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel A33 promoter-based conditionally replicative adenovirus suppresses tumor growth and eradicates hepatic metastases in human colon cancer models.
    Cafferata EG; Macció DR; Lopez MV; Viale DL; Carbone C; Mazzolini G; Podhajcer OL
    Clin Cancer Res; 2009 May; 15(9):3037-49. PubMed ID: 19336523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reovirus and tumor oncolysis.
    Kim M; Chung YH; Johnston RN
    J Microbiol; 2007 Jun; 45(3):187-92. PubMed ID: 17618222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual effect of Kras(D12) knockdown on tumorigenesis: increased immune-mediated tumor clearance and abrogation of tumor malignancy.
    Smakman N; Veenendaal LM; van Diest P; Bos R; Offringa R; Borel Rinkes IH; Kranenburg O
    Oncogene; 2005 Dec; 24(56):8338-42. PubMed ID: 16091732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy.
    Zhang Y; Gu J; Zhao L; He L; Qian W; Wang J; Wang Y; Qian Q; Qian C; Wu J; Liu XY
    Cancer Res; 2006 Apr; 66(8):4291-8. PubMed ID: 16618754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single Amino Acid Differences between Closely Related Reovirus T3D Lab Strains Alter Oncolytic Potency
    Mohamed A; Clements DR; Gujar SA; Lee PW; Smiley JR; Shmulevitz M
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31748391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reovirus as an experimental therapeutic for brain and leptomeningeal metastases from breast cancer.
    Yang WQ; Senger DL; Lun XQ; Muzik H; Shi ZQ; Dyck RH; Norman K; Brasher PM; Rewcastle NB; George D; Stewart D; Lee PW; Forsyth PA
    Gene Ther; 2004 Nov; 11(21):1579-89. PubMed ID: 15372068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ cancer vaccination with a replication-conditional HSV for the treatment of liver metastasis of colon cancer.
    Endo T; Toda M; Watanabe M; Iizuka Y; Kubota T; Kitajima M; Kawakami Y
    Cancer Gene Ther; 2002 Feb; 9(2):142-8. PubMed ID: 11857031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations for intravascular administration of oncolytic herpes virus for the treatment of multiple liver metastases.
    Nomura N; Kasuya H; Watanabe I; Shikano T; Shirota T; Misawa M; Sugimoto H; Kanazumi N; Nomoto S; Takeda S; Nakao A
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):321-30. PubMed ID: 18575868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage metalloelastase (MME) as adjuvant for intra-tumoral injection of oncolytic adenovirus and its influence on metastases development.
    Lavilla-Alonso S; Bauer MM; Abo-Ramadan U; Ristimäki A; Halavaara J; Desmond RA; Wang D; Escutenaire S; Ahtiainen L; Saksela K; Tatlisumak T; Hemminki A; Pesonen S
    Cancer Gene Ther; 2012 Feb; 19(2):126-34. PubMed ID: 22095385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.